Davos-Klosters, 20 – 24 January 2025
Discover our interview in the DAVOS Interview Series, where we discuss the importance of collaboration in addressing complex scientific challenges in immunotherapy.
About miDiagnostics
miDiagnostics is at the forefront of advancing healthcare through innovative silicon chip technology, delivering miniaturized, rapid, and user-friendly lab-quality tests directly to patients and clinicians. By integrating a nanofluidic processor on a chip with a compact reader, miDiagnostics is capable of measuring a wide array of biomarkers from minimally invasive samples.
Aligned with our mission to enhance the safety and efficacy of various therapies, we are committed to providing reliable and innovative sterility testing and other quality assurance services that empower biopharmaceutical companies. This commitment ensures compliance with the highest industry standards and fosters trust in advanced therapeutic solutions.
